We Use Cookies

This website uses cookies to optimize performance, preferences, usage and statistics. By accepting them, you consent to store on your device only the cookies that don't require consent. You can check our privacy policy page for more information.

Biomarkers and Surrogate Endpoints in Drug Development

 

As more biomarkers and surrogate endpoints are identified and utilized, they can enhance the research and development process of new medicines by providing new ways to measure disease activity and the impact of the medicines being studied.